NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
基本信息
- 批准号:7765562
- 负责人:
- 金额:$ 30.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinomaAdenocarcinoma CellAdultAffectAge-YearsAmericanApoptosisBarrett EsophagusBiochemistryBiological MarkersBiopsyCell CycleCell LineCell ProliferationCellsCessation of lifeCyclic AMP-Responsive DNA-Binding ProteinCyclin D1DNA DamageDNA-dependent protein kinaseDataDeath DomainDevelopmentDysplasiaEarly DiagnosisEnzymesEsophagealEsophageal AdenocarcinomaEsophageal Intraepithelial NeoplasiaEsophageal mucous membraneEsophagusFetal KidneyFigs - dietaryFree RadicalsFundingG1 PhaseGastroesophageal reflux diseaseGrantHumanHydrogen PeroxideInferior esophageal sphincter structureInflammationInflammation MediatorsInflammatoryIntestinal MetaplasiaInvestigationJournalsLeadLipidsMalignant NeoplasmsMalignant neoplasm of esophagusManuscriptsMediatingMetaplasiaMetaplastic CellMitogensModelingMucous MembraneMutationNADPNADPH OxidaseNF-kappa BNuclearOxidasesPathway interactionsPatientsPhosphorylationPhysiologic pulsePhysiologyPlatelet Activating FactorPlayPrevention approachPrincipal InvestigatorProductionProtein IsoformsProteinsPublishingReactive Oxygen SpeciesRefluxRegulationResearchRetinoblastoma ProteinRho-associated kinaseRiskRisk FactorsRoleSTAT proteinSignal PathwaySignal Transduction PathwaySmall Interfering RNASmooth MuscleSourceStructureTestingThymidineTissuesUp-Regulationcyclooxygenase 2designgenetic regulatory proteinhuman CYBA proteinnoveloverexpressionpreventpublic health relevancetherapeutic targettranscription factortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Gastroesophageal reflux disease (GERD) affects more than one in ten adults over 40 years of age and one in four adults over 60. Approximately 10% of GERD patients develop Barrett's esophagus (BE), which is associated with nearly a 30-125-fold increased risk for the development of esophageal adenocarcinoma (EA). The mechanism of progression from BE to dysplasia and to EA is unknown. We will therefore examine some of the pathways that may be involved in this progression. Reactive oxygen species (ROS) are elevated in BE and EA, and may play a key role in the progression from BE to EA. We found that a novel isoform of NADPH oxidase NOX5-S is overexpressed in EA cell lines, EA tissues, and BE mucosa with high grade dysplasia. NOX5-S was first identified in human fetal kidney and has not been described in other tissues. In SEG1 EA cells pulsed acid exposure causes upregulation of NOX5-S and increases H2O2 production. NOX5-S-derived ROS contribute to increased cell proliferation and decreased apoptosis in SEG1 cells. However, the mechanisms of acid-induced NOX5-S upregulation and NOX5-S-dependent increase in cell proliferation and decrease in apoptosis are not fully understood. We will therefore test the hypothesis that acid exposure upregulates NADPH oxidases via activation of Rho kinases and MAP kinases in Barrett's metaplastic cells, causing overproduction of free radicals, which in turn may further enhance the expression of NADPH oxidases through activation of the nuclear factor kappaB (NF-kB). In addition, ROS may upregulate cyclin D1 and the silencer of the death domain (SODD). Upregulation of cyclin D1 and SODD will increase cell proliferation and decrease apoptosis in these cells. Thus the persistent acid reflux present in BE patients may cause high levels of ROS, increased cell proliferation and decreased apoptosis, which may lead to DNA damage and increased mutations, contributing to the progression from BE to dysplasia and to EA. To test this hypothesis we will: 1) Examine the signal transduction pathway of acid-induced expression of NADPH oxidases in a BE cell line, in Barrett's mucosal biopsies, and in EA cells (SEG1, FLO, and OE33). We will focus on the role of Rho kinase, MAP kinases and NF-kB. 2) Examine the mechanisms of NADPH oxidase-dependent increase in cell proliferation and decrease in apoptosis, concentrating on the role of cyclin D1 and SODD, and examine whether NADPH oxidase-derived ROS cause DNA damage. 3) Examine the regulatory proteins required for NOX5-S to function, focusing on Rac1 and p22phox. A better understanding of the signal transduction pathway of acid induced upregulation of NADPH oxidases, leading to increased cell proliferation and decreased apoptosis, may provide a rational approach to the prevention of development of EA. In addition, NOX5-S may be a potential biomarker for early detection of esophageal dysplasia. Our model may also be applicable to other inflammation-associated cancers.
PUBLIC HEALTH RELEVANCE: This proposal studies the role of a particular enzyme NOX5-S in the progression from Barrett's esophagus, a condition where cells in the esophagus have been altered by acid reflux, to esophageal cancer. This project is designed to find potential therapeutic targets to prevent this progression.
描述(由申请人提供):胃食管反流病(GERD)影响超过十分之一的40岁以上成人和四分之一的60岁以上成人。大约10%的GERD患者发展为巴雷特食管(BE),这与食管腺癌(EA)发展风险增加近30-125倍有关。从BE进展到发育不良和EA的机制尚不清楚。因此,我们将研究一些可能参与这种进展的途径。活性氧(ROS)在BE和EA中升高,并且可能在BE向EA的进展中起关键作用。我们发现一种新的NADPH氧化酶NOX 5-S亚型在EA细胞系、EA组织和具有高度异型增生的BE粘膜中过表达。NOX 5-S首先在人胎儿肾脏中被鉴定,在其他组织中尚未被描述。在SEG 1 EA细胞中,脉冲酸暴露引起NOX 5-S的上调并增加H2 O2的产生。NOX 5-S衍生的ROS有助于增加SEG 1细胞的细胞增殖和减少细胞凋亡。然而,酸诱导的NOX 5-S上调和NOX 5-S依赖性的细胞增殖增加和凋亡减少的机制尚未完全了解。因此,我们将测试酸暴露通过激活Barrett化生细胞中的Rho激酶和MAP激酶上调NADPH氧化酶的假设,导致自由基的过度产生,这反过来又可能通过激活核因子κ B(NF-κ B)进一步增强NADPH氧化酶的表达。此外,ROS可能上调细胞周期蛋白D1和死亡结构域沉默物(SODD)。细胞周期蛋白D1和SODD的上调将增加这些细胞中的细胞增殖并减少细胞凋亡。因此,BE患者中存在的持续性酸反流可能导致高水平的ROS、增加的细胞增殖和减少的细胞凋亡,这可能导致DNA损伤和增加的突变,从而促进从BE到发育不良和EA的进展。为了检验这一假设,我们将:1)检查BE细胞系、Barrett粘膜活检和EA细胞(SEG 1、FLO和OE 33)中酸诱导的NADPH氧化酶表达的信号转导途径。我们将重点讨论Rho激酶、MAP激酶和NF-kB的作用。2)研究NADPH氧化酶依赖性的细胞增殖增加和细胞凋亡减少的机制,集中于细胞周期蛋白D1和SODD的作用,并研究NADPH氧化酶衍生的ROS是否导致DNA损伤。3)检查NOX 5-S发挥功能所需的调节蛋白,重点是Rac 1和p22 phox。更好地理解酸诱导的NADPH氧化酶上调的信号转导途径,导致细胞增殖增加和凋亡减少,可能提供一个合理的方法来预防EA的发展。此外,NOX 5-S可能是早期检测食管异型增生的潜在生物标志物。我们的模型也可能适用于其他炎症相关的癌症。
公共卫生关系:这项提案研究了一种特殊的酶NOX 5-S在从巴雷特食管(Barrett's esophagus)发展到食管癌的过程中的作用,巴雷特食管是一种食管细胞因酸反流而改变的疾病。该项目旨在寻找潜在的治疗靶点,以防止这种进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEIBIAO CAO其他文献
WEIBIAO CAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEIBIAO CAO', 18)}}的其他基金
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
8068799 - 财政年份:2009
- 资助金额:
$ 30.59万 - 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
- 批准号:
7960509 - 财政年份:2009
- 资助金额:
$ 30.59万 - 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
8461663 - 财政年份:2009
- 资助金额:
$ 30.59万 - 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
7578120 - 财政年份:2009
- 资助金额:
$ 30.59万 - 项目类别:
NADPH oxidase-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
8278044 - 财政年份:2009
- 资助金额:
$ 30.59万 - 项目类别:
NADPH oxidases-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
7013516 - 财政年份:2006
- 资助金额:
$ 30.59万 - 项目类别:
NADPH oxidases-associated transition from Barrett's esophagus to adenocarcinoma
NADPH 氧化酶相关的巴雷特食管向腺癌的转变
- 批准号:
7229819 - 财政年份:2006
- 资助金额:
$ 30.59万 - 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
- 批准号:
7381875 - 财政年份:2006
- 资助金额:
$ 30.59万 - 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS, SUBTITLE:
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制,副标题:
- 批准号:
7171101 - 财政年份:2005
- 资助金额:
$ 30.59万 - 项目类别:
COBRE: RIH: THEME B: PATHOGENESIS OF GI TUMORS, GERD, ESOPHAGITIS
COBRE:RIH:主题 B:胃肠道肿瘤、胃食管反流病、食管炎的发病机制
- 批准号:
6981778 - 财政年份:2004
- 资助金额:
$ 30.59万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Assessing The Impact of Heparanase and NDST2 Expression on Non-Small Cell Lung Adenocarcinoma Cell Motility
评估乙酰肝素酶和 NDST2 表达对非小细胞肺腺癌细胞运动的影响
- 批准号:
449570 - 财政年份:2020
- 资助金额:
$ 30.59万 - 项目类别:
Studentship Programs
Analysis of cancer metastasis and invasion mechanism using a new lung adenocarcinoma cell line.
使用新的肺腺癌细胞系分析癌症转移和侵袭机制。
- 批准号:
16K10689 - 财政年份:2016
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acquisition strategy of tumor-specific markers using established micropapillary pattern pulmonary adenocarcinoma cell line
使用已建立的微乳头模式肺腺癌细胞系获取肿瘤特异性标志物的策略
- 批准号:
26460441 - 财政年份:2014
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The antibetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
抗生素药物二甲双胍在体外和体内抑制食管腺癌细胞增殖。
- 批准号:
25860540 - 财政年份:2013
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
细胞通透肽抑制胰腺导管腺癌细胞增殖,可作为分子靶向药物
- 批准号:
25461969 - 财政年份:2013
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Research for elucidation of chemo-resistance in mucinous adenocarcinoma cell.
阐明粘液腺癌细胞化疗耐药性的基础研究。
- 批准号:
22791532 - 财政年份:2010
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
TAS::75 0849::TAS IN THIS PHASE I SBIR THE BREAST CANCER ADENOCARCINOMA CELL LI
TAS::75 0849::TAS 在这一阶段 I SBIR 乳腺癌腺癌细胞 LI
- 批准号:
8164743 - 财政年份:2010
- 资助金额:
$ 30.59万 - 项目类别:
Role of Endothelin-1 in osteoblastic bone metastasis produced by a human lung adenocarcinoma cell line
Endothelin-1 在人肺腺癌细胞系产生的成骨细胞骨转移中的作用
- 批准号:
19790127 - 财政年份:2007
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CONNEXIN 43 EXPRESSION IN ADENOCARCINOMA CELL LINE
连接蛋白 43 在腺癌细胞系中的表达
- 批准号:
6972483 - 财政年份:2004
- 资助金额:
$ 30.59万 - 项目类别:
The mechanisms of highly metastetic capasity in highly metastatic subpopulations of lung adenocarcinoma cell line and these clinical applications
肺腺癌细胞系高转移亚群的高转移能力机制及临床应用
- 批准号:
15590831 - 财政年份:2003
- 资助金额:
$ 30.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)